PSMA PET and radiomics for the evaluation of liver metastases in castration-resistant prostate cancer patients: a multicenter retrospective study

被引：0
|
作者：
Mattoni, S. [1 ]
Formaggio, F. [1 ]
Bruno, G. [2 ]
Caroli, P. [3 ]
Cerci, J. [4 ]
Eiber, M. [5 ]
Fendler, W. [6 ]
Golfieri, R. [7 ]
Herrmann, K. [6 ]
Matteucci, F. [3 ]
Mosconi, C. [7 ]
Paolani, G. [8 ]
Santoro, M. [8 ]
Strigari, L. [8 ]
Nanni, C. [1 ]
Castellucci, P. [1 ]
Fanti, S. [1 ]
Farolfi, A. [1 ]
机构：
[1] Univ Bologna, Div Nucl Med, IRCCS Azienda Osped, Bologna, Italy
[2] Fdn Ctr Diagnost Nucl FCDN, Buenos Aires, DF, Argentina
[3] Ist Sci Romagnolo Studio Cura Tumori Dino Amadori, Dept Nucl Med, Meldola, Italy
[4] Quanta Diagnost & Terapia, Dept Nucl Med, Curitiba, Parana, Brazil
[5] Tech Univ Munich TUM, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany
[6] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany
[7] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany
[8] IRCCS Azienda Osped Univ Bologna, Dept Radiol, Bologna, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0655
引用
收藏
页码：S234 / S234
页数：1
相关论文
共 50 条
  • [1] PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study
    Mattoni, Susanna
    Farolfi, Andrea
    Formaggio, Fabio
    Bruno, Gabriel
    Caroli, Paola
    Cerci, Juliano Julio
    Eiber, Matthias
    Fendler, Wolfgang Peter
    Golfieri, Rita
    Herrmann, Ken
    Matteucci, Federica
    Mosconi, Cristina
    Paolani, Giulia
    Santoro, Miriam
    Strigari, Lidia
    Nanni, Cristina
    Castellucci, Paolo
    Fanti, Stefano
    CANCERS, 2022, 14 (22)
  • [2] Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study
    Gacci, Mauro
    Marchioni, Michele
    De Francesco, Piergustavo
    Natoli, Clara
    Calabro, Fabio
    Losanno, Tania
    Gianmartin, Cito
    Serni, Sergio
    Doni, Laura
    De Nunzio, Cosimo
    De Tursi, Michele
    Valeriani, Maurizio
    Giacinti, Silvana
    Alvarez-Maestro, Mario
    Scarcia, Marcello
    Ludovico, Giuseppe M.
    Del Bene, Gabriella
    Simone, Giuseppe
    Ferriero, Mariaconsiglia
    Tuderti, Gabriele
    Bove, Pierluigi
    Laudisi, Anastasia
    Carrieri, Giuseppe
    Cormio, Luigi
    Verze, Paolo
    La Rocca, Roberto
    Falsaperla, Mario
    Frantellizzi, Viviana
    Greco, Francesco
    Di Nicola, Marta
    Schips, Luigi
    Cindolo, Luca
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (04): : 489 - 497
  • [3] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Jensen, A.
    Karunaratna, N.
    Wong, S.
    Shapiro, J.
    Weickhardt, A.
    Spain, L.
    Azad, A. A.
    Kwan, E.
    Muthusamy, A.
    Torres, J.
    Parente, P.
    Francis, P.
    Parnis, F. X.
    Goh, J.
    Gibbs, P.
    Tran, B.
    Anton, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1329 - S1330
  • [4] PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
    Weber, Manuel
    Kurek, Claudia
    Barbato, Francesco
    Eiber, Matthias
    Maurer, Tobias
    Nader, Michael
    Hadaschik, Boris
    Gruewald, Viktor
    Herrmann, Ken
    Wetter, Axel
    Fendler, Wolfgang P.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (01) : 88 - 91
  • [5] PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?
    Urso, Luca
    Filippi, Luca
    Castello, Angelo
    Marzola, Maria Cristina
    Bartolomei, Mirco
    Cittanti, Corrado
    Florimonte, Luigia
    Castellani, Massimo
    Zucali, Paolo
    Bruni, Alessio
    Sabbatini, Roberto
    Dominici, Massimo
    Panareo, Stefano
    Evangelista, Laura
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [6] FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Zukotynski, Katherine A.
    Jadvar, Hossein
    Cho, Steve Y.
    Kim, Chun Ki
    Cline, Kathryn
    Emmenegger, Urban
    Hotte, Sebastien J.
    Pond, Gregory Russell
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [7] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Karunaratna, Nathasha
    Jensen, Andrew
    Wong, Shirley
    Shapiro, Julia
    Weickhardt, Andrew
    Spain, Lavinia
    Azad, Arun
    Kwan, Edmond M.
    Muthusamy, Arun
    Torres, Javier
    Parente, Phillip
    Parnis, Francis
    Goh, Jeffrey
    Gibbs, Peter
    Tran, Ben
    Anton, Angelyn
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 58 - 58
  • [8] PSMA PET–CT redefines nonmetastatic castration-resistant prostate cancer
    Piet Ost
    Nature Reviews Urology, 2020, 17 : 133 - 134
  • [9] Novel Framework for Treatment Response Evaluation in Patients With Metastatic Castration-Resistant Prostate Cancer Using PSMA PET/CT (RECIP): An International Multicenter Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 10 - 11
  • [10] Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer
    Fankhauser, Christian Daniel
    Poyet, Cedric
    Kroeze, Stephanie G. C.
    Kranzbuhler, Benedikt
    Schuler, Helena I. Garcia
    Guckenberger, Matthias
    Kaufmann, Philipp A.
    Hermanns, Thomas
    Burger, Irene A.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (03) : 457 - 467
12345